Riskpilot← Back to searchSign inGet full accessKALLOS AS
ASActiveOrg 927142465Kleivbrottet 1, 3084 HolmestrandOther human health activities n.e.c. · NACE 8699Est. 20210 employees
Revenue 2024
NOK 600K
+33% vs 2023
EBITDA margin
10.6%
+577% vs 2023
Equity ratio
91.5%
Financial strength
Net profit 2024
NOK 62K
+572% vs 2023
| Revenue | NOK 600K | +33% |
| EBITDA | NOK 63K | +577% |
| Net profit | NOK 62K | +572% |
| Total assets | NOK 295K | +23% |
| Equity | NOK 270K | +30% |
| Employees | 0 | — |
Legal name
KALLOS AS
Org number
927142465
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
25. mai 2021
Share capital
NOK 300 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Tilby hudbehandlinger innen kosmetisk dermatologisk medisin. Fokus blir å øke bevissthet og kunnskap om hudhelse blant befolkningen, og forebygging av ulike hudtilstander / sykdommer i alle aldersgrupper. Selskapet har helhetlig tilnærming til hud og helse, og skal tilby helhetlig livsstilsveiledning. Samtidig skal virksomheten tilby minimalt invasive hudbehandlinger hvis behov i samarbeid med ansvarlig lege / hudlege. Norge viser høye tall med hudkreft statistikker, hudkreft som er direkte forårsaket av uv radiasjon. Jeg ønsker å øke bevisstheten og kunnskapen om hudhelse i samfunnet på individ og nasjonalt nivå. Virksomheten vil i tillegg drive med salg av hudpleie produkter.
Address
Kleivbrottet 1, 3084 Holmestrand
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 157 | 452 | 450 | 600 |
| Staff expenses | −0 | −0 | −0 | −113 |
| EBITDA | −194 | 115 | −13 | 63 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −194 | 115 | −13 | 63 |
| Net financials | 0 | 0 | 0 | −1 |
| Profit before tax | −194 | 116 | −13 | 62 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −194 | 116 | −13 | 62 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 204 | 296 | 240 | 295 |
| Equity | 106 | 221 | 208 | 270 |
| Long-term debt | 77 | 37 | 7 | 0 |
| Short-term debt | 21 | 38 | 25 | 25 |
| Total debt | 99 | 75 | 32 | 25 |
EBITDA margin
10.6%
This company
15.8%
Market median
-33% vs market
20212024
Equity ratio
91.5%
This company
38.2%
Market median
+140% vs market
20212024
Return on equity
23.0%
This company
18.4%
Market median
+25% vs market
20212024
Net profit margin
10.4%
This company
8.1%
Market median
+28% vs market
20212024
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20212024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-05-03 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IS Deputy Member | Deputy Member | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KALLOS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingebret Sele | Deputy Member | 0 companies |
| Jurgita Sele | Chairman | 0 companies |